- Current report filing (8-K)
January 09 2012 - 7:30AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13
or 15(d) of the
Securities Exchange Act
of 1934
Date of Report (Date of earliest event reported):
January 9, 2012
MAKO Surgical Corp.
(Exact name of registrant as specified in its
charter)
Delaware
|
001-33966
|
20-1901148
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
2555 Davie Road
Fort Lauderdale, Florida 33317
(Address of principal executive offices and
zip code)
Registrant’s telephone number, including
area code:
(954) 927-2044
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02.
Results of Operations and Financial Condition.
On January 9, 2012, MAKO Surgical Corp. (the “
Company
”)
issued a press release, furnished as Exhibit 99.1 and incorporated into this Form 8-K by reference, announcing the number of RIO®
Robotic Arm Interactive Orthopedic Systems sold, the number of MAKOplasty® Total Hip Arthroplasty (THA) applications sold,
the percentage of domestic commercial installed base having the MAKOplasty THA application, and the number of MAKOplasty procedures
performed in 2011, as well as the Company’s 2012 annual guidance.
The information in this Form 8-K and the exhibit attached
hereto pertaining to the Company’s operating results and guidance shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except
as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
|
|
Description of Exhibit
|
|
|
|
99.1
|
|
Press Release issued by MAKO Surgical Corp. on January 9, 2012
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
MAKO Surgical Corp.
|
|
|
|
|
|
|
|
|
|
Date: January 9, 2012
|
By:
|
/s/ Fritz L. LaPorte
|
|
|
|
Fritz L. LaPorte, Senior Vice President of Finance and Administration, Chief Financial Officer and Treasurer
|
|
EXHIBIT INDEX
Exhibit No.
|
|
Description of Exhibit
|
|
|
|
99.1
|
|
Press Release issued by MAKO Surgical Corp. on January 9, 2012
|
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jul 2023 to Jul 2024